Cesar Jimenez - Publications

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Journal: JAMA

Published: February 05, 2025

Bacterial Infection Features in Alcohol-Associated Hepatitis: Review of a 2016-2021 Cohort.

Journal: Journal of clinical medicine

Published: August 09, 2024

Prophylactic antibiotics in patients with alcohol-associated hepatitis receiving steroids: A systematic review and meta-analysis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 27, 2024

Identification of injured elements in computational models of spinal cord injury using machine learning.

Journal: Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference

Published: December 12, 2023

An artificial intelligence-generated model predicts 90-day survival in alcohol-associated hepatitis: A global cohort study.

Journal: Hepatology (Baltimore, Md.)

Published: December 07, 2023

Clinical, experimental and pathophysiological effects of Yaq-001: a non-absorbable, gut-restricted adsorbent in models and patients with cirrhosis.

Journal: Gut

Published: July 16, 2023

Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.

Journal: Gut

Published: March 22, 2023

Sympathetic nervous activation, mitochondrial dysfunction and outcome in acutely decompensated cirrhosis: the metabolomic prognostic models (CLIF-C MET).

Journal: Gut

Published: September 16, 2022

MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis.

Journal: JHEP reports : innovation in hepatology

Published: August 06, 2022

Value of pilot studies in alcohol-associated hepatitis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: April 24, 2022

Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: October 09, 2021

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.

Journal: Hepatology communications

Published: May 28, 2021